The overall goal of this grant application is to understand the regulatory pathways that control the regenerative capacity of hematopoietic stem cells (HSCs) during stress hematopoiesis. A clear understanding of how signaling pathways are used to balance HSC self-renewal and differentiation for efficient hematopoietic regeneration is still lacking. It is unclear how signaling pathways control HSC self-renewal in concert with other regulatory elements. This lack of knowledge has hampered our ability to prevent the decline in HSC regenerative capacity associated with stress hematopoiesis and, consequently, has limited the success of HSC-based therapies that require high numbers of HSC. We have recently discovered a novel and clinically important regulatory network of HSC self-renewal, involving crosstalk between Rho GTPase signaling pathways and mitochondria functions that limit HSC regenerative capacity. We reported that genetic deletion of p190-B Rho GTPase Activating Protein (p190-B RhoGAP [p190-B]); a suppressor of Rho GTPase activity, in mice enhanced long-term HSC engraftment and prevented HSC depletion over serial competitive repopulation. P190-B knock-down in human CD34+ cells preserved huCD34+ functions during ex vivo culture. Single cell assays revealed that p190-B loss promoted HSC self-renewal decision over differentiation during divisions; but HSC quiescence and blood lineage development were not affected. Mechanistically, p190-B loss enhanced HSC self-renewal by limiting mitochondrial oxidative stress and subsequent abnormal activation of an autocrine TGF/p38MAPK stress signaling pathway. We propose that p190-B uses mitochondria to convert oxidative stress into autocrine cytokine signals to instruct HSC fate decision during HSC regeneration.
Aim 1 will determine mechanism linking p190-B and Rho signaling to autocrine TGF1 pathway for HSC self-renewal via.
Aim 2 will define how p190-B uses mitochondria and oxidative energy to modulate TGF - mediated HSC self-renewal.
Aim3 will test the effects of pharmacological inhibition of these pathways on human CD34+ fitness in xeno-transplant models. The proposed studies are innovative because it explores the role of major stress pathways in an underexplored fundamental aspect of HSC biology - i.e. a HSC decision to self-renew or to differentiate independent on mature lineage differentiation or HSC quiescence. The work is expected to yield novel insights in mechanism of HSC self-renewal by crosstalk between signaling and mitochondrial metabolism. This study may ultimately lead to the identification of novel targets for pharmacological intervention in regenerative medicine.

Public Health Relevance

Hematopoietic stem cell self-renewal is a fundamental process to maintain continuous blood cell production throughout life. Deregulation of HSC self-renewal leads to cancer or tissue degeneration. The tremendous potential of HSC to reconstitute the hematopoietic system has allowed the development of clinical HSC transplantation to treat a wide variety of diseases, including bone marrow failure or leukemias. The success of HSC transplantation is however limited due to our inability to control HSC functions. The studies proposed in this application will provide important information of cooperative roles of stress signaling pathways and mitochondrial oxidative metabolism in the regulation of HSC self-renewal. Therefore, our study will guide designing strategies to modulate HSC functions via small molecule inhibitors that could be used in the future to device new therapeutic approaches of clinical HSC transplantation protocols.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK102890-04
Application #
9526479
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Bishop, Terry Rogers
Project Start
2015-07-01
Project End
2019-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Hinge, Ashwini; Xu, Juying; Javier, Jose et al. (2017) p190-B RhoGAP and intracellular cytokine signals balance hematopoietic stem and progenitor cell self-renewal and differentiation. Nat Commun 8:14382
Kumar, Sachin; Filippi, Marie-Dominique (2016) An Alternative Approach for Sample Preparation with Low Cell Number for TEM Analysis. J Vis Exp :
Rai, Parul; Malik, Punam (2016) Gene therapy for hemoglobin disorders - a mini-review. J Rare Dis Res Treat 1:25-31
Hinge, Ashwini; Filippi, Marie-Dominique (2016) Deconstructing the Complexity of TGF? Signaling in Hematopoietic Stem Cells: Quiescence and Beyond. Curr Stem Cell Rep 2:388-397